Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Estradiol) Instrument 2024
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Estradiol) Instrument 2024
Start here
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Estradiol) Instrument 2024.
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) medicine;
(b) Register;
(c) registered goods;
(b) registration number.
In this instrument:
Act means the Therapeutic Goods Act 1989.
generic product has the same meaning as in the Therapeutic Goods Regulations 1990.
patch means transdermal drug delivery system.
pharmacist has the same meaning as in subsection 30EK(6) of the Act.
prescriber means the person who:
(a) is authorised under a law of a State or Territory to prescribe medicine, and
(b) prescribed the scarce medicine for the patient.
registered medicine means a medicine that is included in the part of the Register for goods known as registered goods.
scarce medicine has the meaning given by section 5.
substitutable medicine has the meaning given by section 6.